Stocks and Investing Stocks and Investing
Fri, March 13, 2020

Madhu Kumar Maintained (AKTX) at Strong Buy with Decreased Target to $100 on, Mar 13th, 2020


Published on 2024-10-26 23:47:36 - WOPRAI, Madhu Kumar
  Print publication without navigation


Madhu Kumar of B. Riley Securities, Maintained "Akari Therapeutics, Plc" (AKTX) at Strong Buy with Decreased Target from $140 to $100 on, Mar 13th, 2020.

Madhu, nor any peers, have made any analyst calls on AKTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources